\
&
Contact us
\
&
Contact us
Formalised under the structure of an institutionalised public-private partnership which ensures that research activities of the aviation industry are aligned with the European Union’s policy priorities, the Clean Aviation JU's programme focuses on three main areas:
These three main areas of research and development are further discussed in the Strategic Research and Innovation Agenda (SRIA).
The Clean Aviation JU has various operational objectives compared to 2020 state-of-the-art aircraft:
Clean Aviation Joint Undertaking builds on its predecessor, the Clean Sky 2 JU programme. As an institutionalised partnership, the Clean Aviation JU does not publish the call for proposals in the regular Horizon Europe work programmes. Rather, Clean Aviation publishes their own work programmes.
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
pascal.verheye@vlaio.be
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
